Projects per year
Personal profile
Areas of expertise
External responsibilities
Diplomas
Areas of expertise
External responsibilities
Diplomas
Education/Academic qualification
Doctor of Pharmacy, Thesis Drug design and developpment, Université de Liège
Award Date: 30 Jun 2000
Fingerprint
Dive into the research topics where Jean-Michel Dogné is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MP2026-increasnet1: An Overview of the Use of Artificial Intelligence in Drug Development
Dogné, J.-M. (PI), Musuamba Tshinanu, F. (PI), Locquet, M. (PI) & Haguet, H. (PI)
15/07/26 → 28/02/27
Project: Research
-
VACCIN'ACT: Towards an active and confident Wallonia in the face of vaccination
Dogné, J.-M. (PI), Locquet, M. (CoI) & Vanbeneden, A. (CoI)
1/11/25 → 31/10/28
Project: Research
-
Use of modelling and simulation approaches to optimise the use of paediatric or alternative formulations.
Wellin, L. (PI), Musuamba Tshinanu, F. (Supervisor) & Dogné, J.-M. (Co-supervisor)
1/10/25 → …
Project: PHD
-
MP-EMA: Belgian representation on the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) 2024-2027
Dogné, J.-M. (PI)
1/07/24 → 30/07/27
Project: Research
-
Complementary Use of Modeling and Simulation Approaches and Quantitative Meta-Analysis for the Optimization of Drug Development and Use: The Case of Oral Contraceptives.
Massaux, C. (PI), Musuamba Tshinanu, F. (Supervisor) & Dogné, J.-M. (Co-supervisor)
1/10/23 → 30/09/27
Project: PHD
-
A FIT-FOR-PURPOSE PHYSIOLOGICALLY BASED PHARMACOKINETIC APPROACH FOR INTRANASAL ANALGESICS: APPLICATION TO KETAMINE AND FENTANYL ANALOGS
Olama, A., Djokoto, H., Dogné, J.-M., Govere, G. S., Haguet, H., Hanquet, L., Wellin, L. & Musuamba Tshinanu, F. (Supervisor), 6 Jun 2026.Research output: Contribution to conference › Abstract › peer-review
-
Andes Hantavirus and Bundibugyo Ebola: Outbreak Communication Must Resist Both Alarmism and Conspiracy
Locquet, M., Van Damme, P. & Dogné, J.-M., 26 Jun 2026, In: BMJ.Research output: Contribution to journal › Comment/debate › peer-review
-
Application of a Stochastic Simulation–estimation Approach to Optimize Pharmacokinetic Study Design in the Context of Paediatric Extrapolation: A Tool to Support Decision-making by Drug Sponsors and Regulators
Djokoto, H. P., Ernst, L., Dogné, J. M. & Musuamba, F. T., 21 Feb 2026, In: Pharmaceutical Research.Research output: Contribution to journal › Article › peer-review
-
CAR-T PERSISTENCE MODELLING: BRIDGING BIOLOGY AND DATA
Hanquet, L., Djokoto, H., Dogné, J.-M., Govere, G. S., Haguet, H., Massaux, C., Olama, A., Wellin, L. & Musuamba Tshinanu, F. (Supervisor), 5 Jun 2026.Research output: Contribution to conference › Abstract › peer-review
Open Access -
Commentary: 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
Locquet, M., Beaudart, C., Douxfils, J., Roberfroid, D., Van Damme, P. & Dogné, J.-M., 2026, In: Frontiers in Public Health. 14, p. 1772406Research output: Contribution to journal › Article › peer-review
Open AccessFile12 Downloads (Pure)
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), Mullier, F. (Contributor), Haguet, H. (Contributor), DOGNE, J.-M. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
-
CCDC 1017215: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J.-M. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J.-L. (Contributor), Pirotte, B. (Contributor), Renard, J.-F. (Contributor) & WINUM, J.-Y. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hd4, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hd4&sid=DataCite
Dataset
-
CCDC 1017214: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J.-M. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J.-L. (Contributor), Pirotte, B. (Contributor), Renard, J.-F. (Contributor) & WINUM, J.-Y. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hc3, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hc3&sid=DataCite
Dataset
-
Clustering and kernel density estimation for assessment of measurable residual disease by flow cytometry
Jacqmin, H. (Contributor), Chatelain, B. (Contributor), Louveaux, Q. (Contributor), Jacqmin, P. (Contributor), Dogné, J.-M. (Contributor), Graux, C. (Contributor) & Mullier, F. (Contributor), Zenodo, 18 May 2020
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, H. (Recipient), Douxfils, J. (Recipient), Mullier, F. (Recipient) & Dogne, J.-M. (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 7 Oral presentation
-
Credibility assessment of model informed drug development approaches in paediatric and rare diseases: a review of EMA submissions and assessment reports from 2014 to 2024
Musuamba Tshinanu, F. (Speaker), Haguet, H. (Speaker), Hanquet, L. (Speaker), Dionisi, M. (Speaker), Govere, G. S. (Speaker), Djokoto, H. (Speaker), Massaux, C. (Speaker) & Dogné, J.-M. (Speaker)
Jun 2025Activity: Talk or presentation types › Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Haguet, H. (Speaker), Douxfils, J. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker), Mullier, F. (Speaker) & Dogne, J.-M. (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Haguet, H. (Speaker), Douxfils, J. (Speaker), Mullier, F. (Speaker), Chatelain, C. (Speaker), Graux, C. (Speaker) & Dogne, J.-M. (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
Press/Media
-
New Findings from University of Namur in the Area of Drug Development Described [From animal testing to model-informed drug development: building on ICH M15 and EMA initiatives to make new approach methodologies (NAMs) deliver]
Dogné, J.-M., Musuamba Tshinanu, F. & Locquet, M.
27/07/26
1 item of Media coverage
Press/Media: Expert Comment
-
-
Minutes of PRAC meeting on 7-10 April 2026
8/06/26
1 item of Media coverage
Press/Media: Expert Comment
-
Reports from University of Namur Add New Data to Findings in Neoplasms (Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications)
25/05/26
1 item of Media coverage
Press/Media: Expert Comment
-
New Findings from University of Namur in the Area of Science Described (Techniques for measuring NETosis: A critical literature review and outlook for standardization)
Dogné, J.-M., Douxfils, J., Mullier, F. & Gillot, C.
21/05/26
1 item of Media coverage
Press/Media: Expert Comment